Skip Navigation LinksHome   |   Reference Center   |   Publication List
  • Print
  • Share

CIBMTR Publication List

Since 1972, use of CIBMTR data and statistical resources have resulted in more than 1,000 publications. These publications are organized by year below, and can be searched to help you quickly find the information you need. 

Display:



2016

Year Title Authors Publication
2016 Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions. Kumar R, Kimura F, Ahn KW, Hu Z-H, Kuwatsuka Y, Klein JP, Pasquini M, Miyamura K, Kato K, Yoshimi A, Inamoto Y, Ichinohe T, Wood WA Jr, Wirk B, Seftel M, Rowlings P, Marks DI, Schultz KR, Gupta V, Dedeken L, George B, Cahn J-Y, Szer J, Lee JW, Ho AY, Fasth A, Hahn T, Khera N, Dalal J, Bonfim C, Aljurf M, Atsuta Y, Saber W Biol Blood Marrow Transplant 22(5):932-940
2016 Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the CIBMTR. Strouse C, Richardson P, Prentice G, Korman S, Hume R, Nejadnik B, Horowitz MM, Saber W Biol Blood Marrow Transplant
2016 Autologous transplant remains the preferred therapy for relapsed APL in CR2. Ganzel C, Mathews V, Alimoghaddam K, Ghavamzadeh A, Kuk D, Devlin S, Wang H, Zhang M-J, Weisdorf D, Douer D, Rowe JM, Polge E, Esteve J, Nagler A, Mohty M, Tallman M Bone Marrow Transplant
2016 Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study Denzen EM, Thao V, Hahn T, Lee SJ, McCarthy PL, Rizzo JD, Ammi M, Drexler R, Flesch S, James H, Omondi N, Murphy E, Pederson K, Majhail NS Bone Marrow Transplant
2016 Killer cell immunoglobulin-like receptor ligand matching and outcomes after unrelated cord blood transplantation acute myeloid leukemia. Rocha V, Ruggeri A, Spellman S, Wang T, Sobecks R, Locatelli F, Askar M, Michel G, Arcese W, Iori AP, Purtill D, Danby R, Sanz GF, Gluckman E, Eapen M Biol Blood Marrow Transplant
2016 Immune-mediated complications after hematopoietic stem cell transplantation. Li Z, Rubinstein SM, Thota R, Savani M, Brissot E, Shaw BE, Majhail NS, Mohty M, Savani BN Biol Blood Marrow Transplant
2016 Scoring system prognostic of outcome in patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome. Shaffer BC, Ahn KW, Hu Z-H, Nishihori T, Malone AK, Valcárcel D, Grunwald MR, Bacher U, Hamilton B, Kharfan-Dabaja MA, Saad A, Cutler C, Warlick E, Reshef R, Wirk BM, Sabloff M, Fasan O, Gerds A, Marks D, Olsson R, Wood WA, Costa LJ, Miller AM, Cortes J, Daly A, Kindwall-Keller TL, Kamble RT, Rizzieri DA, Cahn J-Y, Gale RP, William B, Litzow M, Wiernik PH, Liesveld J, Savani BN, Vij R, Ustun C, Copelan E, Popat U, Kalaycio M, Maziarz R, Alyea E, Sobecks R, Pavletic S, Tallman M, Saber W J Clin Oncol
2016 Impact of early CMV reactivation in cord blood stem cell recipients in the current era. Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn KW, Chen M, Green J, Laughlin M, Lazarus HM, Marks D, Saad A, Seftel M, Saber W, Savani BN, Waller E, Wingard J, Auletta JJ, Lindemans CA, Boeckh M, Riches ML Bone Marrow Transplant
2016 GVHD after HLA-matched sibling BMT or PBSCT: comparison of North American Caucasian and Japanese populations. Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W Biol Blood Marrow Transplant 22(4):744-751
2016 The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis. Williams KM, Ahn KW, Chen M, Aljurf MD, Agwu AL, Chen AR, Walsh TJ, Szabolcs P, Boeckh MJ, Auletta JJ, Lindemans CA, Zanis-Neto J, Malvezzi M, Lister J, de Toledo Codina JS, Sackey K, Chakrabarty JLH, Ljungman P, Wingard JR, Seftel MD, Seo S, Hale GA, Wirk B, Smith MS, Savani BN, Lazarus HM, Marks DI, Ustun C, Abdel-Azim H, Dvorak CC, Szer J, Storek J, Yong A, Riches MR Bone Marrow Transplant 51(4):573-580
2016 Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium - Haplo2014, San Francisco, California, December 4, 2014. Al Malki MM, Horowitz M, Handgretinger R, Leung W, Roy D-C, Huang X-J, Fuchs E, Locatelli F, Blaise D, Mineishi S, Martelli M, Miller J, June C, Ai H-S, Luznik L, Mavilio D, Lugli E, van den Brink MRM, Champlin RE, Ciurea SO Biol Blood Marrow Transplant 22(4):594-604
2016 New light chain amyloid response criteria help risk stratification of patients by day 100 after autologous hematopoietic cell transplant. D'Souza A, Huang J, Hari P Biol Blood Marrow Transplant 22(4):768-770
2016 7/8 and 9/10 or better high resolution match rate for the Be The Match® Unrelated Donor Registry. Buck K, Wadsworth K, Setterholm M, Maiers M, Confer D, Hartzman R, Schmidt A, Yang SY, Dehn J Biol Blood Marrow Transplant 22(4):759-763
2016 Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms. Hanif A, Hari PN, Atallah E, Carlson K-SB, Pasquini MC, Michaelis LC Bone Marrow Transplant 51(4):617-618
2016 Efficacy of pharmacokinetics-directed busulfan, cyclophosphamide and etoposide conditioning and autologous stem cell transplantation for lymphoma: comparison of a multicenter phase 2 study and CIBMTR outcomes. Flowers CR, Costa LJ, Pasquini MC, Le-Rademacher J, Lill M, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, Braunschweig I, Ai W, Yeh RF, Rodriguez TE, Flinn I, Comeau T, Yeager AM, Pulsipher MA, Bence-Bruckler I, Laneuville P, Bierman P, Chen AI, Kato K, Wang Y, Xu C, Smith AJ, Waller EK Biol Blood Marrow Transplant
2016 Diversity in Exon 5 of HLA-C∗04:01:01G is significant in anthropological studies. Dunn PPJ, Lamb G, Selwyn C, Compton J, Yang E, Maiers M, Fernandez-Vina M Hum Immunol
2016 Haematopoietic cell transplants in Latin America. Gale RP, Seber A, Bonfim C, Pasquini M Bone Marrow Transplant
2016 Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. Fenske TS, Ahn KW, Graff TM, DiGilio A, Bashir Q, Kamble RT, Ayala E, Bacher U, Brammer JE, Cairo M, Chen A, Chen Y-B, Chhabra S, D'Souza A, Farooq U, Freytes C, Ganguly S, Hertzberg M, Inwards D, Jaglowski S, Kharfan-Dabaja MA, Lazarus HM, Nathan S, Pawarode A, Perales M-A, Reddy N, Seo S, Sureda A, Smith SM, Hamadani M Br J Haematol
2016 Long-term survival, organ function and malignancy after hematopoietic stem cell transplantation for Fanconi anemia. Bonfim C, Ribeiro L, Nichele S, Bitencourt M, Loth G, Koliski A, Funke VAM, Pilonetto DV, Pereira NF, Flowers MED, Velleuer E, Dietrich R, Fasth A, Torres-Pereira CC, Pedruzzi P, Eapen M, Pasquini R Biol Blood Marrow Transplant
2016 Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children (<18y) and Young adults (18-29y) with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis Chaudhury S, Sparapani R, Hu ZH, Nishihori T, Abdel-Azim H, Malone A, Olsson R, Hamadani M, Daly A, Bacher U, Wirk BM, Kamble RT, Gale RP, Wood WA, Hale G, Wiernik PH, Hashmi SK, Marks DI, Ustun C, Munker R, Savani BN, Alyea E, Popat U, Sobecks R, Kalaycio M, Maziarz R, Hijiya N, Saber W Biol Blood Marrow Transplant
2016 A proportional hazards regression model for the subdistribution with covariates-adjusted censoring weight for competing risks data. He P, Eriksson F, Scheike TH, Zhang M-J Scand Stat Theory Appl 43(1):103-122
2016 Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission. Seftel MD, Neuberg D, Zhang M-J, Wang H-L, Ballen KK, Bergeron J, Couban S, Freytes CO, Hamadani M, Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Paulson K, Saber W, Sallan SE, Soiffer R, Tallman MS, Woolfrey AE, DeAngelo DJ, Weisdorf DJ Am J Hematol 91(3):322-329
2016 Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers. Preussler JM, Mau L-W, Majhail NS, Bevans M, Clancy E, Messner C, Parran L, Pederson KA, Ferguson SS, Walters K, Murphy EA, Denzen EM Support Care Cancer 24(3):1167-1174
2016 Significant improvements in the practice patterns of adult related donor care in US transplantation centers. Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV Biol Blood Marrow Transplant 22(3):520-527
2016 European Group for Blood and Marrow Transplantation centers with FACT-JACIE accreditation have significantly better compliance with related donor care standards. Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE Biol Blood Marrow Transplant 22(3):514-519
2016 On modeling Human Leukocyte antigen-identical sibling match probability for allogeneic hematopoietic cell transplantation: estimating the need for an unrelated donor source. Besse K, Maiers M, Confer D, Albrecht M Biol Blood Marrow Transplant 22(3):410-417
2016 Observational studies: matching or regression? Brazauskas R, Logan BR Biol Blood Marrow Transplant 22(3):557-563
2016 Asymmetric linkage disequilibrium: tools for assessing multiallelic LD. Single RM, Strayer N, Thomson G, Paunic V, Albrecht M, Maiers M Hum Immunol 77(3):288-294
2016 The GL service: web service to exchange GL string encoded HLA & KIR genotypes with complete and accurate allele and genotype ambiguity. Milius RP, Heuer M, George M, Pollack J, Hollenbach JA, Mack SJ, Maiers M Hum Immunol 77(3):249-256
2016 Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application. Torikai H, Mi T, Gragert L, Maiers M, Najjar A, Ang S, Maiti S, Dai J, Switzer KC, Huls H, Dulay GP, Reik A, Rebar EJ, Holmes MC, Gregory PD, Champlin RE, Shpall EJ, Cooper LJN Sci Rep 6:21757
2016 Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, Bouzas LF, Confer D, Greinix H, Horowitz M, Iida M, Lipton J, Mohty M, Novitzky N, Nunez J, Passweg J, Pasquini MC, Kodera Y, Apperley J, Seber A, Gratwohl A Bone Marrow Transplant
2016 Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia Munker R, Brazauskas R, Wang HL, de Lima M, Khoury HJ, Gale RP, Maziarz RT, Sandmaier BM, Weisdorf D, Saber W Biol Blood Marrow Transplant
2016 Harvests from bone marrow donors who weigh less than their recipients are associated with a significantly increased probability of a suboptimal harvest yield. Anthias C, Billen A, Arkwright R, Szydlo RM, Madrigal JA, Shaw BE Transfusion
2016 Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors. Kanate AS, Mussetti A, Kharfan-Dabaja MA, Ahn KW, DiGilio A, Beitinjaneh A, Chhabra S, Fenske TS, Freytes C, Gale RP, Ganguly S, Hertzberg M, Klyuchnikov E, Lazarus HM, Olsson R, Perales M-A, Rezvani A, Riches M, Saad A, Slavin S, Smith SM, Sureda A, Yared J, Ciurea S, Armand P, Salit R, Bolaños-Meade J, Hamadani M Blood 127(7):938-947
2016 Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis. Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ Blood
2016 Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and survival free of progression and GVHD (GRFS) Van Besien K, Hari P, Zhang M-J, Liu H-T, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman S, Artz A Haematologica
2016 Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Riches ML, Trifilio S, Chen M, Ahn KW, Langston A, Lazarus HM, Marks DI, Martino R, Maziarz RT, Papanicolou GA, Wingard JR, Young J-AH, Bennett CL Bone Marrow Transplant 51(2):277-282
2016 Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation. Pagliuca S, Gérard L, Kulasekararaj A, Eapen M, Boutboul D, Martin H, Salvino MA, Knol-Bout C, Dufour C, Peffault de Latour R, Marsh J Bone Marrow Transplant 51(2):313-315
2016 Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Riches ML, Trifilio S, Chen M, Ahn KW, Langston A, Lazarus HM, Marks DI, Martino R, Maziarz RT, Papanicolou GA, Wingard JR, Young J-AH, Bennett CL Bone Marrow Transplant
2016 Infections following transplantation of bone marrow or peripheral-blood stem cells from unrelated donors. Young JAH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JM, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C Biol Blood Marrow Transplant 22(2):359-370
2016 Hematopoietic cell transplantation outcomes in monosomal karyotype myeloid malignancies. Pasquini MC, Zhang M-J, Medeiros BC, Armand P, Hu Z-H, Nishihori T, Aljurf MD, Akpek G, Cahn J-Y, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA Jr, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ Biol Blood Marrow Transplant 22(2):248-257
2016 DAS181 treatment of severe parainfluenza virus 3 pneumonia in allogeneic hematopoietic stem cell transplant recipients requiring mechanical ventilation. Dhakal B, D'Souza A, Pasquini M, Saber W, Fenske TS, Moss RB, Drobyski WR, Hari P, Abidi MZ Case Rep Med 2016:8503275
2016 The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Kollman C, Spellman SR, Zhang M-J, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales M-A, Setterholm M, Woolfrey AE, Yu N, Eapen M Blood 127(2):260-267
2016 Global use of peripheral blood vs bone marrow as source of stem cells for allogeneic transplantation in patients with bone marrow failure. Yoshimi A, Baldomero H, Horowitz M, Szer J, Niederwieser D, Gratwohl A, Kodera Y JAMA 315(2):198-200
2016 Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Wood WA, Le Rademacher J, Syrjala KL, Jim H, Jacobsen PB, Knight JM, Abidi MH, Wingard JR, Majhail NS, Geller NL, Rizzo JD, Fei M, Wu J, Horowitz MM, Lee SJ Cancer 122(1):91-98
2016 Determination of eligibility in related pediatric hematopoietic cell donors: ethical and clinical considerations. Recommendations from a working group of the Worldwide Network for Blood and Marrow Transplantation Association. Bitan M, van Walraven SM, Worel N, Ball LM, Styczynski J, Torrabadella M, Witt V, Shaw BE, Seber A, Yabe H, Greinix HT, Peters C, Gluckman E, Rocha V, Halter J, Pulsipher MA Biol Blood Marrow Transplant 22(1):96-103
2016 Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes. Nakasone H, Sahaf B, Tian L, Wang T, Haagenson MD, Schoenrock K, Perloff S, Ryan CE, Wu F, Spellman SR, Lee SJ, Ritz J, Miklos DB Haematologica 101(1):e30-e33
2016 Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE Bone Marrow Transplant 51(1):83-88
2016 Low socioeconomic status, adverse gene expression profiles, and clinical outcomes in hematopoietic stem cell transplant recipients. Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JMG, Ma J, Cole SW Clin Cancer Res 22(1):69-78
2016 Analysis of a genetic plymorphism in the costimulatory molecule TNFSF4 with hematopoietic stem cell transplant outcomes. Jindra PT, Conway SE, Ricklefs SM, Porcella SF, Anzick SL, Haagenson M, Wang T, Spellman S, Milford E, Kraft P, McDermott DH, Abdi R Biol Blood Marrow Transplant 22(1):27-36
2016 Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma. Klyuchnikov E, Bacher U, Woo Ahn K, Carreras J, Kröger NM, Hari PN, Ku GH, Ayala E, Chen AI, Chen Y-B, Cohen JB, Freytes CO, Gale RP, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Martino R, Mussetti A, Savani BN, Schouten HC, Usmani SZ, Wiernik PH, Wirk B, Smith SM, Sureda A, Hamadani M Bone Marrow Transplant 51(1):58-66
 
 
​​​​​

View current and planned studies
Last Updated: 3/23/2016 9:32 AM